Family Practice News Digital Network PHOENIX – The recently approved diabetes drug canagliflozin improved beta-cell function in patients with advanced type 2 diabetes inadequately controlled with metformin plus sulfonylurea , according to a phase III study. Although some of the changes did ... and more »
Family Practice News Digital Network ORLANDO – Metformin may be associated with a reduced risk of colorectal cancer in patients with type 2 diabetes, according to a meta-analysis that included mostly observational studies. Sulfonylurea and insulin were not associated with a reduced risk ... and more »
Family Practice News Digital Network PHOENIX – The recently approved diabetes drug canagliflozin improved beta-cell function in patients with advanced type 2 diabetes inadequately controlled with metformin plus sulfonylurea , according to a phase III study. Although some of the changes did ... and more »
Family Practice News Digital Network ORLANDO – Metformin may be associated with a reduced risk of colorectal cancer in patients with type 2 diabetes, according to a meta-analysis that included mostly observational studies. Sulfonylurea and insulin were not associated with a reduced risk ... and more »
Telegraph.co.uk However, the final draft guidance still does not recommend Forxiga as a triple therapy in combination with metformin and sulfonylurea , another blood-sugar-lowering drug. The agency changed its position on the drug after requesting further information ...
WebMD.Boots.com Dapagliflozin is now being recommended in combination with metformin or insulin therapy for some people with type 2 diabetes. It is not recommended as an...
Family Practice News Digital Network PHOENIX – The recently approved diabetes drug canagliflozin improved beta-cell function in patients with advanced type 2 diabetes inadequately controlled with metformin plus sulfonylurea , according to a phase III study. Although some of the changes did ... and more »
Family Practice News Digital Network ORLANDO – Metformin may be associated with a reduced risk of colorectal cancer in patients with type 2 diabetes, according to a meta-analysis that included mostly observational studies. Sulfonylurea and insulin were not associated with a reduced risk ... and more »
Family Practice News Digital Network PHOENIX – The recently approved diabetes drug canagliflozin improved beta-cell function in patients with advanced type 2 diabetes inadequately controlled with metformin plus sulfonylurea , according to a phase III study. Although some of the changes did ... and more »
Family Practice News Digital Network ORLANDO – Metformin may be associated with a reduced risk of colorectal cancer in patients with type 2 diabetes, according to a meta-analysis that included mostly observational studies. Sulfonylurea and insulin were not associated with a reduced risk ... and more »
